1-5 of 5
Paul Bröckelmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembro-CORE: Interim analysis of a phase II PET-adapted trial omitting high-dose chemotherapy with PD-1-based salvage in first-relapsed Hodgkin lymphoma

Free
Hishan Tharmaseelan, Sarah Gillessen, Ina Bühnen, Carsten Kobe, Karin G. Schrenk, Prof. Dr. Max S Topp, Ulf Schnetzke, Nico Freund, Stephanie Sasse, Philipp Ernst, Tanja Zamrik, Wolfram Klapper, Michael Fuchs, Sven Borchmann, Paul Bröckelmann, Peter Borchmann, Bastian von Tresckow
Journal: Blood
Blood (2025) 146 (Supplement 1): 5401.
https://doi.org/10.1182/blood-2025-5401
Published: 2025
Journal Articles

Comprehensive analysis of bridging to CAR-T cell therapy in large B-cell lymphoma with conventional treatment or the CD3xCD20 bispecific antibody glofitamab

Free
Ruth Fluemann, Anne-Catherine Neumann, Julia Schleifenbaum, Noelle Sieg, Hanna Zieger, Anna Luetz, Conrad-Amadeus Voltin, David Stahl, Justin Ferdinandus, Sebastian Theobald, Martin Thelen, Paul Bröckelmann, Jessica Schneider, Daniel Bachurski, Philipp Schommers, Max Szameitat, Nadine Kutsch, Philipp Gödel, Jan-Michel Heger, Dennis Eichenauer, Sven Borchmann, Jörn Meinel, Johannes Rosenbrock, Bastian von Tresckow, Peter Borchmann, Ron D. Jachimowicz
Journal: Blood
Blood (2025) 146 (Supplement 1): 3734.
https://doi.org/10.1182/blood-2025-3734
Published: 2025
Journal Articles

Effects of antibiotic prophylaxis in first-line therapy of advanced stage classic Hodgkin lymphoma: An analysis of the GHSG HD21 study

Free
Hishan Tharmaseelan, Janina Jablonski, Gundolf Schneider, Helen Kaul, Christian Jaworek, Anne Sophie Robertz, Justin Ferdinandus, Michael Fuchs, Paul Bröckelmann, Jannik Stemler, Peter Borchmann
Journal: Blood
Blood (2025) 146 (Supplement 1): 3626.
https://doi.org/10.1182/blood-2025-3626
Published: 2025
Journal Articles

Phase II Study of Ofatumumab in Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report from the German Hodgkin Study Group

Free
Dennis A. Eichenauer, MD, Helen Goergen, Annette Pluetschow, Karolin Behringer, MD, Stefanie Kreissl, MD, Paul Bröckelmann, MD, Michael Fuchs, MD, Boris Böll, MD, Bastian von Tresckow, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2015) 126 (23): 2729.
https://doi.org/10.1182/blood.V126.23.2729.2729
Published: 2015
Journal Articles

Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials

Free
Boris Böll, MD, Karolin Behringer, MD, Helen Görgen, Paul Bröckelmann, MD, Bastian von Tresckow, MD, Dennis A. Eichenauer, MD, Michael Fuchs, MD, Volker Diehl, MD, Andreas Engert, MD, Peter Borchmann, MD
Journal: Blood
Blood (2014) 124 (21): 3062.
https://doi.org/10.1182/blood.V124.21.3062.3062
Published: 2014